Herbs (Global Traditional) · European
Lavandula angustifolia (Lavender)
Strong Evidencebotanical
Hermetica Superfood Encyclopedia
Lavandula angustifolia contains linalool and linalyl acetate as primary bioactive compounds that modulate GABA neurotransmitter activity. These compounds cross the blood-brain barrier to provide anxiolytic and sedative effects through GABAergic pathways.
Lavandula angustifolia (English lavender) is a fragrant shrub from the Lamiaceae family native to the Mediterranean region, particularly thriving in dry, sunny environments. The plant's flowers and leaves are processed via steam distillation for essential oil or aqueous/ethanol extraction for herbal preparations. Chemically classified as an aromatic herb rich in monoterpenes and phenolic compounds.
A systematic review of seven RCTs involving 852 patients demonstrated lavender's effectiveness for depression, particularly as an adjunct therapy. Another meta-analysis confirmed significant anxiolytic effects of oral lavender essential oil, while a single-blind RCT in 52 postoperative cardiac patients showed aromatherapy benefits for pain and sleep. Most evidence comes from small-to-moderate trials with calls for larger studies.
Clinically studied oral doses include 80 mg/day of standardized lavender extract (e.g., Silexan containing 80 mg linalool and acetyl linalool) for 10 weeks for anxiety and sleep. Aromatherapy protocols use undiluted essential oil inhalation, though specific volumes vary. No powder forms have been clinically studied. Consult a healthcare provider before starting any new supplement.
Lavandula angustifolia is primarily utilized as an aromatic and medicinal herb rather than a significant dietary source of macronutrients. Key bioactive compounds and their approximate concentrations include: **Essential oil (1–3% of dry flower weight)** composed principally of linalool (25–45%), linalyl acetate (25–47%), 1,8-cineole (up to 2.5%), camphor (0.5–1.5%), lavandulol (>0.3%), terpinen-4-ol (1–5%), β-caryophyllene (2–5%), and trace amounts of limonene, ocimene, and geraniol. **Polyphenolic compounds:** rosmarinic acid (approximately 1.5–5.0 mg/g dry weight), caffeic acid, luteolin, luteolin-7-O-glucoside, and apigenin (collectively contributing to antioxidant capacity; total phenolic content approximately 20–60 mg GAE/g dry extract depending on extraction method). **Flavonoids:** total flavonoid content approximately 5–15 mg quercetin equivalents/g dry weight. **Tannins:** present at approximately 5–12% in aqueous extracts. **Minerals (per 100 g dried herb, approximate):** calcium (~215 mg), iron (~12 mg), magnesium (~60 mg), potassium (~250 mg), zinc (~1.5 mg), and manganese (~2 mg). **Vitamins:** trace amounts of vitamin A (as carotenoid precursors) and vitamin C (~2–4 mg/100 g dried herb), though these are not nutritionally significant at typical usage doses. **Macronutrients (per 100 g dried herb, approximate):** dietary fiber ~25–30 g, protein ~4–5 g, fat ~1–2 g (largely essential oil fraction), carbohydrates ~50–55 g. **Caloric value:** approximately 200–250 kcal/100 g dried herb, though typical culinary or therapeutic doses (1–3 g) contribute negligible calories. **Bioavailability notes:** Linalool and linalyl acetate are rapidly absorbed orally and via inhalation, with peak plasma concentrations achieved within 30–60 minutes of oral administration; rosmarinic acid has moderate oral bioavailability (~1–5%) due to ester hydrolysis in the gut; polyphenol bioavailability is enhanced when consumed with lipids or in encapsulated formulations. Standardized oral preparations (e.g., Silexan®) deliver 80 mg essential oil per capsule with demonstrated systemic availability of key terpenoids.
Linalool and linalyl acetate in lavender essential oil bind to GABA-A receptors, enhancing inhibitory neurotransmission in the central nervous system. These compounds also modulate voltage-gated calcium channels and inhibit glutamate release, contributing to anxiolytic effects. Additionally, lavender constituents influence the hypothalamic-pituitary-adrenal axis, reducing cortisol levels during stress responses.
A systematic review of 7 RCTs (n=852) demonstrated moderate evidence for lavender as an adjunct treatment for depression management. Meta-analyses confirm oral lavender essential oil significantly reduces anxiety symptoms compared to placebo across multiple studies. Clinical trials using 80mg daily of standardized lavender oil (Silexan) show measurable anxiety reduction within 2 weeks. Evidence strength is considered moderate due to variable study methodologies and small sample sizes in some trials.
Lavender supplements are generally well-tolerated with mild side effects including nausea, belching, and drowsiness in some users. Topical application may cause contact dermatitis in sensitive individuals. Lavender may enhance the sedative effects of CNS depressants, benzodiazepines, and alcohol. Pregnant and breastfeeding women should avoid therapeutic doses due to insufficient safety data, though culinary amounts are considered safe.
